Methods of reduction of interpatient variability

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/13 (2006.01) A61K 31/404 (2006.01) A61K 31/4184 (2006.01) A61K 31/421 (2006.01) A61P 3/00 (2006.01)

Patent

CA 2758588

Disclosed herein are methods for the reduction of inter-patient variability of a drug, such as in one or more parameters including half- life (t1/2), maximum plasma concentration (C max), time at maximal plasma concentration (T max), area under the time-versus-concentration curve (AUC). Also provided are methods of reducing side effects associated with drugs.

Les procédés selon l'invention permettent de réduire la variabilité d'un médicament d'un patient à l'autre, par exemple, au niveau d'un ou de plusieurs paramètres comprenant la demi-vie (t1/2), la concentration plasmatique maximale (Cmax), le temps à la concentration plasmatique maximale (Tmax), l'aire sous la courbe de concentration dans le temps (AUC). Des procédés permettant de réduire les effets secondaires associés auxdits médicaments sont également décrits.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of reduction of interpatient variability does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of reduction of interpatient variability, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of reduction of interpatient variability will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1830599

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.